» Authors » Jonica Campolo

Jonica Campolo

Explore the profile of Jonica Campolo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 58
Citations 446
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Campolo J, Annoni G, Giaccardi M, Andreassi M
J Cardiovasc Dev Dis . 2022 Aug; 9(8). PMID: 36005409
Epidemiological studies have shown an increased prevalence of cancer in patients with congenital heart disease (CHD) as compared with the general population. The underlying risk factors for the acquired cancer...
12.
Belli O, Campolo J, Vallerio P, Musca F, Moreo A, Maloberti A, et al.
Cardiovasc Ultrasound . 2022 Mar; 20(1):6. PMID: 35331262
Background: Septic shock is a severe form of sepsis marked by hypotension with an ominous outcome despite the introduction of modern intensive care. The aim of the present study is...
13.
Campolo J, Corradi E, Parolini M, Di Guglielmo M, Rizzardi A, Dellanoce C, et al.
Oxid Med Cell Longev . 2021 Dec; 2021:9713582. PMID: 34868459
The hyperproduction of oxidative stress and inflammatory biomarkers, which is paralleled by decreased levels of antioxidant and anti-inflammatory mediators, is part of cellular mechanisms that contribute to the disruption of...
14.
Caselli C, De Caterina R, Smit J, Campolo J, El Mahdiui M, Ragusa R, et al.
Sci Rep . 2021 Oct; 11(1):20714. PMID: 34671067
We assessed whether high triglycerides (TG) and low high-density lipoprotein cholesterol (HDL-C) levels, expressed by an increased TG/HDL-C ratio, predict coronary atherosclerotic disease (CAD) outcomes in patients with stable angina....
15.
Kanoni S, Kumar S, Amerikanou C, Kurth M, Stathopoulou M, Bourgeois S, et al.
Front Immunol . 2021 May; 12:683028. PMID: 34025683
Clinical Trial Registration: ClinicalTrials.gov, identifier NCT03135873.
16.
Amerikanou C, Kanoni S, Kaliora A, Barone A, Bjelan M, DAuria G, et al.
Mol Nutr Food Res . 2021 Feb; 65(10):e2001178. PMID: 33629536
Scope: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease with poor therapeutic strategies. Mastiha possesses antioxidant/anti-inflammatory and lipid-lowering properties. The authors investigate the effectiveness of Mastiha as...
17.
Campolo J, Corradi E, Rizzardi A, Parolini M, Dellanoce C, Di Guglielmo M, et al.
Eur Arch Otorhinolaryngol . 2021 Jan; 278(6):2055. PMID: 33475858
No abstract available.
18.
Morici N, Marini C, Sacco A, Tavazzi G, Cipriani M, Oliva F, et al.
Am Heart J . 2020 Dec; 233:39-47. PMID: 33338464
Background: Cardiogenic shock (CS) is a systemic disorder associated with dismal short-term prognosis. Given its time-dependent nature, mechanical circulatory support may improve survival. Intra-aortic balloon pump (IABP) had gained widespread...
19.
Campolo J, Corradi E, Rizzardi A, Parolini M, Dellanoce C, Di Guglielmo M, et al.
Eur Arch Otorhinolaryngol . 2020 Oct; 278(6):2047-2054. PMID: 33108562
Purpose: This study evaluates among middle-aged subjects with obesity the prevalence of olfactory impairment (OI) with respect to normative values and its correlation with body composition, cognition, sleep quality, and...
20.
Sbrana S, Campolo J, Clemente A, Bastiani L, Cecchettini A, Ceccherini E, et al.
Biomed Res Int . 2020 Aug; 2020:8748934. PMID: 32802883
Background And Aims: Atherosclerosis is an inflammatory disease with long-lasting activation of innate immunity and monocytes are the main blood cellular effectors. We aimed to investigate monocyte phenotype (subset fraction...